The battle with the host over microbial size

Current Opinion in Microbiology

Volumn 16, Issue 1, 2013, Pages 59-62

  Weiser, Jeffrey N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G;

AGGLUTINATION TEST; ANTIGEN BINDING; ANTIMICROBIAL ACTIVITY; BACTERIAL VIRULENCE; BIOFILM; BODY SURFACE; CELL DIVISION; CELL STRUCTURE; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HOST; HOST RESISTANCE; HUMAN; HYDROLYSIS; IMMUNE RESPONSE; KLEBSIELLA PNEUMONIAE; MACROPHAGE; MICROBIAL COLONIZATION; MICROBIAL SIZE; MICROBIOLOGICAL PARAMETERS; MICROORGANISM; MOLECULAR INTERACTION; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; REVIEW; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; VIRULENCE;

BACTERIA; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; IMMUNITY, INNATE; VIRULENCE; VIRULENCE FACTORS;

EID: 84875809713     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.01.001     Document Type: Review

References (31)

1. Young K. The selective value of bacterial shape. Microbial Mol Biol Rev 2006, 70:660-703.
2. Justice S., Hung C., Theriot J., Fletcher D., Anderson G., Footer M., Hultgren S. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA 2004, 101:1333-1338.
3. Okagaki L., Strain A., Nielsen J., Charlier C., Baltes N., Chretien F., Heitman J., Dromer F., Nielsen K. Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 2010, 6:e1000953.
4. Sycuro L., Pincus Z., Gutierrez K., Biboy J., Stern C., Vollmer W., Salama N. Peptidoglycan crosslinking relaxation promotes Helicobacter pylori's helical shape and stomach colonization. Cell 2010, 141:822-833.
5. Zaragoza O., Garci{dotless}a-Rodas R., Nosanchuk J., Cuenca-Estrella M., Rodri{dotless}guez-Tudela J., Casadevall A. Fungal cell gigantism during mammalian infection. PLoS Pathog 2010, 6:e1000945.
6. Justice S., Hunstad D., Cegelski L., Hultgren S. Morphological plasticity as a bacterial survival strategy. Nat Rev Microbiol 2008, 6:162-168.
7. Horvath D.J., Li B., Casper T., Partida-Sanchez S., Hunstad D., Hultgren S., Justice S. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect 2011, 13:426-437.
8. Bjarnsholt T., Jensen P., Burmolle M., Hentzer M., Haagensen J., Hougen H., Calum H., Madsen K., Moser C., Molin S., et al. Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent. Microbiology 2005, 151:373-383.
9. Labro M., Pochet I., Babin-Chevaye C., Hakim J. Effect of ceftriaxone-induced alterations of bacteria on neutrophil bactericidal function. J Antimicrob Chemother 1987, 20:857-869.
10. Koval M., Preiter K., Adles C., Stahl P., Steinberg T. Size of IgG-opsonized particles determines macrophage response during internalization. Exp Cell Res 1998, 242:265-273.
11. Rodriguez J., Dalia A., Weiser J. Increased chain length promotes pneumococcal adherence and colonization. Infect Immun 2012, 80:3454-3459.
12. Dalia A., Weiser J. Minimization of bacterial size allows for complement evasion and is overcome by the agglutinating effect of antibody. Cell Host Microbe 2011, 10:486-496.
13. Picard C., Puel A., Bustamante J., Ku C., Casanova J. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol 2003, 3:451-459.
14. Ram S., Lewis L., Rice P. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev 2010, 23:740-780.
15. Jensen E., Kharazmi A., Garred P., Kronborg G., Fomsgaard A., Mollnes T., Høiby N. Complement activation by Pseudomonas aeruginosa biofilms. Microb Pathog 1993, 15:377-388.
16. Stryker L. Variations in the pneumococcus induced by growth in immune serum. J Exp Med 1916, 24:49-68.
17. Bull C. The agglutination of bacteria in vivo. J Exp Med 1915, 22:484-491.
18. Bull C. The mechanism of the curative action of antipneumococcus serum. J Exp Med 1915, 22:457-464.
19. Margni R., Parma E., Cerone S., Erpelding A., Perdigon G. Agglutinating and non-agglutinating antibodies in rabbits inoculated with a particulate antigen (Salmonella typhimurium). Immunology 1983, 48:351-359.
20. Ax W., Kanzy E., Seiler F. In-vivo phagocytosis: enhancement of bacterial clearance by native and enzyme-treated immunoglobulins. Immunobiology 1981, 159:349-365.
21. Trautmann M., Triest K., Hofstaetter T., Seiler F., Hahn H. Influence of different immunoglobulin G preparations on phagocytosis of Pseudomonas aeruginosa by polymorphonuclear granulocytes. Zentralbl Bakteriol Mikrobiol Hyg 1985, 259:104-117.
22. Amulic B., Hayes G. Neutrophil extracellular traps. Curr Biol 2011, 21:R297-R298.
23. Papayannopoulos V., Zychlinsky A. NETs: a new strategy for using old weapons. Trends Immunol 2009, 30:513-521.
24. Martin J.L.M., Gullstrand B., Tydén H., Lood C., Truedsson L., Bengtsson A., Blom A. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012, 188:3522-3531.
25. Chu H., Pazgier M., Jung G., Nuccio S., Castillo P., de Jong M., Winter M., Winter S., Wehkamp J., Shen B., et al. Human α-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 2012, 337:477-481.
26. Bender M.H., Weiser J.N. The atypical amino-terminal LPNTG-containing domain of the pneumococcal human IgA1-specific protease is required for proper enzyme localization and function. Mol Microbiol 2006, 61:526-543.
27. Kilian M., Reinholdt J. Immunoglobulin A1 proteases of pathogenic and commensal bacteria of the respiratory tract. Colonization of Mucosal Surfaces 2005, 119-130. American Society for Microbiology Press, Washington, DC. N. JP (Ed.).
28. Kilian M., Reinholdt J., Lomholt H., Poulsen K., Frandsen E. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence. APMIS 1996, 104:321-338.
29. Sumby P., Barbian K., Gardner D., Whitney A., Welty D., Long R., Bailey J., Parnell M., Hoe N., Adams G., et al. Extracellular deoxyribonuclease made by group A Streptococcus assists pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci USA 2005, 102:1679-1684.
30. Walker M., Hollands A., Sanderson-Smith M., Cole J., Kirk J., Henningham A., McArthur J., Dinkla K., Aziz R., Kansal R., et al. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 2007, 13:981-985.
31. Berends E., Horswill A., Haste N., Monestier M., Nizet V., von Köckritz-Blickwede M. Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J Innate Immun 2010, 2:576-586.